Manufacturing roundup: Merck KGaA plans new facility in South Korea; Daewoong invests $75M into new plant for Botox rival
German pharma manufacturer Merck KGaA has inked a memorandum of understanding with South Korea’s Ministry of Trade, Industry and Energy and Daejeon City to build …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.